Ticagrelor
- Product NDC
- 71610-958
- 11-digit product format
- 716100958
- Labeler code
- 71610
- Product ID
- 71610-958_445e4a36-0326-75ec-e063-6294a90aaa26
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ticagrelor
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA208584
- Marketing category
- ANDA
- Marketing start
- 2025-05-01
- Substance
- TICAGRELOR
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ticagrelor
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TICAGRELOR | 90 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GLH0314RVC |
| Rxcui | 1116635 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-958-41 | Ticagrelor | 5400 in 1 BOTTLE | TABLET | 5400 | | 2 |
| 71610-958-42 | Ticagrelor | 1800 in 1 BOTTLE | TABLET | 1800 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-958-41 | 71610095841 | 5400 TABLET in 1 BOTTLE (71610-958-41) | 5400 tablet | 2025-10-22 | No | No | Historical |
| 71610-958-42 | 71610095842 | 1800 TABLET in 1 BOTTLE (71610-958-42) | 1800 tablet | 2025-11-21 | No | No | Historical |